Chat with us, powered by LiveChat
  • Get inspired by peer-reviewed publications of our scientists, partners, and customers around the globe.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

Trust Built on Excellence

The satisfaction and loyalty of our customers drive our success at MIMETAS


The trust placed in us by top global pharmaceutical and biotech players is a testament to the exceptional quality and value we deliver. With unwavering expertise and dedication, we continuously strive to provide you with outstanding results while staying at the forefront of scientific advancements.

All Specialized Know-how Under One Roof

In the rapidly evolving field of disease modeling, expertise is vital. That's why we have curated a comprehensive range of expertise under one roof at MIMETAS. Our team combines crucial biological knowledge, efficient supply chain management, cutting-edge hardware capabilities, and advanced data interpretation techniques to meet your unique requirements. Our specialities include:

  • High-throughput screening
  • Adult-stem cell Organoid-based models
  • Biobanks
  • Automation
  • Artifical Intelligence

Explore our offerings

Impacting Drug Discovery Shoulder-to-Shoulder

Roche Partnership

In July 2021, MIMETAS and Roche entered a risk-sharing collaboration to develop human disease models for the characterization of novel compounds in Inflammatory Bowel Disease (IBD) and Hepatitis B virus infections (HBV). Under the terms of the agreement, MIMETAS is eligible to receive an upfront payment and milestone payments from Roche. You can find the original press release here. We are delighted to share that the partnership is going well and recently achieved important milestones in the project.

 

Astellas Pharma Inc. Partnership

In March 2023, MIMETAS and Astellas Pharma Inc. entered a strategic partnership. The partnership, which was then expanded in June 2023 to include automation and support, comprises utilizing MIMETAS’ comprehensive tumor models to support the next generation of immuno-oncological therapies. Under this collaboration, Astellas will receive access to MIMETAS immune oncological disease assays. MIMETAS will be eligible for upfront and milestone payments.

Learn more about Drug Discovery

You Are at The Center of Our Success

The satisfaction and loyalty of our customers drive our success at MIMETAS. With unwavering expertise and dedication, we continuously strive to provide you with outstanding results while staying at the forefront of scientific advancements. Read some success stories from our customers:

Work with us

Marking 10 years of impactful science, we're dedicated to further leveraging our 3D tissue expertise to provide tailored answers to your unique research questions.We foster effective collaborations, long-term relationships, and tangible impact on your therapeutic programs. We strongly value your success and plan carefully to ensure that we address your specific research questions in full. Please reach out if you would like to work together.

Contact us

Cookies

‘May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy

Accept all
Accept selected
Decline all